Clinical Trial: High Velocity Nasal Insufflation Versus Continuous Positive Airway Pressure in COVID 19 Pneumonic Patients

U.S., Oct. 10 -- ClinicalTrials.gov registry received information related to the study (NCT07213518) titled 'High Velocity Nasal Insufflation Versus Continuous Positive Airway Pressure in COVID 19 Pneumonic Patients' on Oct. 02.

Brief Summary: compare the efficacy of High-Velocity Nasal Insufflation (HVNI) versus Continuous Positive Airway Pressure (CPAP) in managing COVID 19 pneumonic patients with acute type 1 respiratory failure

Study Start Date: Jan. 01, 2022

Study Type: INTERVENTIONAL

Condition: COVID-19 Pneumonia

Intervention: DEVICE: High Velocity Nasal Insufflation

COVID 19 Pneumonic Patients with Acute Type 1 Respiratory Failure received High Velocity Nasal Insufflation

DEVICE: Continuous Positive Airway Pressure

COVID 19...